Stay updated on Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial
Sign up to get notified when there's something new on the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page.

Latest updates to the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page’s footer version indicator has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site software update rather than a change to the study content.SummaryDifference0.0%

- Check22 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check51 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check87 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed, along with the removal of the funding-status notice. These are administrative updates that do not alter the study details or results presented on the page.SummaryDifference0.3%

- Check94 days agoChange DetectedAdded a notice about a lapse in government funding and NIH operating status with a link to opm.gov and cc.nih.gov. Updated page version to v3.4.1.SummaryDifference0.3%

Stay in the know with updates to Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page.